FGFR2 and osteosarcoma: 44% of 64 osteosarcoma tumors had focal amplification and 30 had deletion of FGFR2. Similarly in humans, FGF receptor genes are frequently amplified in different cancer types: including FGFR1 and FGFR2 in sarcomas and osteosarcoma [40].